Combined Triple Therapy in Diabetic Retinopathy (DRP)
NCT00806169
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Macular Edema
Diabetic Retinopathy
Interventions
DRUG:
triamcinolone and bevacizumab
Sponsor
Johann Wolfgang Goethe University Hospital